Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fuji
Moodys
US Department of Justice
Federal Trade Commission
Healthtrust
Harvard Business School
US Army
Johnson and Johnson

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021840

« Back to Dashboard

NDA 021840 describes SEASONIQUE, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the SEASONIQUE profile page.

The generic ingredient in SEASONIQUE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 021840
Tradename:SEASONIQUE
Applicant:Teva Branded Pharm
Ingredient:ethinyl estradiol; levonorgestrel
Patents:4
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021840
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SEASONIQUE ethinyl estradiol; levonorgestrel TABLET;ORAL 021840 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA ,Inc. 0093-3134 N 0093-3134-82
SEASONIQUE ethinyl estradiol; levonorgestrel TABLET;ORAL 021840 NDA Teva Women's Health, Inc. 51285-087 N 51285-087-87

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.03MG,0.01MG;0.15MG,N/A
Approval Date:May 25, 2006TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 30, 2024Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION
Patent:➤ Try a Free TrialPatent Expiration:Jun 15, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY
Patent:➤ Try a Free TrialPatent Expiration:Dec 5, 2028Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
US Department of Justice
Accenture
Fish and Richardson
AstraZeneca
Covington
Queensland Health
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.